BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11241172)

  • 1. Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor.
    Dickson SE; Bicknell R; Fraser HM
    J Endocrinol; 2001 Mar; 168(3):409-16. PubMed ID: 11241172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.
    Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R
    Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy.
    Rowe AJ; Morris KD; Bicknell R; Fraser HM
    Biol Reprod; 2002 Oct; 67(4):1180-8. PubMed ID: 12297534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).
    Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary.
    Fraser HM; Hastings JM; Allan D; Morris KD; Rudge JS; Wiegand SJ
    Endocrinology; 2012 Apr; 153(4):1972-83. PubMed ID: 22334711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.
    Fraser HM; Wilson H; Wulff C; Rudge JS; Wiegand SJ
    Reproduction; 2006 Oct; 132(4):589-600. PubMed ID: 17008470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum.
    Redmer DA; Doraiswamy V; Bortnem BJ; Fisher K; Jablonka-Shariff A; Grazul-Bilska AT; Reynolds LP
    Biol Reprod; 2001 Sep; 65(3):879-89. PubMed ID: 11514354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
    Al-zi'abi MO; Watson ED; Fraser HM
    Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization.
    Wulff C; Dickson SE; Duncan WC; Fraser HM
    Hum Reprod; 2001 Dec; 16(12):2515-24. PubMed ID: 11726568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats.
    Kashida S; Sugino N; Takiguchi S; Karube A; Takayama H; Yamagata Y; Nakamura Y; Kato H
    Biol Reprod; 2001 Jan; 64(1):317-23. PubMed ID: 11133689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in the corpus luteum.
    Reynolds LP; Grazul-Bilska AT; Redmer DA
    Endocrine; 2000 Feb; 12(1):1-9. PubMed ID: 10855683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey.
    Zimmermann RC; Xiao E; Husami N; Sauer MV; Lobo R; Kitajewski J; Ferin M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):768-72. PubMed ID: 11158044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and manipulation of angiogenesis in the primate corpus luteum.
    Fraser HM; Lunn SF
    Reproduction; 2001 Mar; 121(3):355-62. PubMed ID: 11226061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate.
    Dickson SE; Fraser HM
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2339-44. PubMed ID: 10852474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in the primate ovary.
    Fraser HM; Wulff C
    Reprod Fertil Dev; 2001; 13(7-8):557-66. PubMed ID: 11999306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation and vascular morphology in the marmoset corpus luteum.
    Young FM; Rodger FE; Illingworth PJ; Fraser HM
    Hum Reprod; 2000 Mar; 15(3):557-66. PubMed ID: 10686196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and localisation of angiotensin II in the bovine early corpus luteum: a possible interaction with luteal angiogenic factors and prostaglandin F2 alpha.
    Kobayashi S; Berisha B; Amselgruber WM; Schams D; Miyamoto A
    J Endocrinol; 2001 Aug; 170(2):369-80. PubMed ID: 11479133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aetiology of attenuated luteal development in prednisolone-induced eosinopenic ewes.
    Murdoch WJ; Van Kirk EA
    Reprod Fertil Dev; 2000; 12(3-4):127-32. PubMed ID: 11302421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque.
    Fraser HM; Wilson H; Morris KD; Swanston I; Wiegand SJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5811-8. PubMed ID: 16046580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.